FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / PeerJ / Impact of body weight gain on hepatic metabolism and hepatic...
PeerJ2019; 7; e7069; doi: 10.7717/peerj.7069

Impact of body weight gain on hepatic metabolism and hepatic inflammatory cytokines in comparison of Shetland pony geldings and Warmblood horse geldings.

Abstract: Non-alcoholic fatty liver disease is known as determining part of human obesity. The impact of body weight (BW) gain on liver metabolism has not been extensively investigated yet. Objective: To investigate hepatic alterations caused by increasing BW in ponies and horses. Methods: A total of 19 non-obese equines (10 Shetland ponies, geldings; nine Warmblood horses, geldings). Methods: Animals received 200% of their metabolizable maintenance energy requirements for 2 years. Serum alkaline phosphatase, glutamate dehydrogenase (GLDH), aspartate aminotransferase (AST), and gamma-glutamyl transferase activities and bile acids were analyzed several times during 2 years of hypercaloric diet. Hepatic lipid content and hepatic levels of the interleukin (IL)-6, tumor necrosis factor α (TNFα), cluster of differentiation (CD) 68, IL-1β, lipoprotein lipase (LPL), fatty acid-binding protein 1, chemerin and nuclear factor-κB mRNAs were assessed at the start of the study and after 1 and 2 years of excess energy intake. Results: The mean (±SD) BW gain recorded during 2 years of excess energy intake was 29.9 ± 19.4% for ponies and 17 ± 6.74% for horses. The hepatic lipid content was not profoundly affected by increasing BW. Levels of the IL-6, TNFα, CD68 and IL-1β mRNAs did not change during BW gain. Levels of the chemerin mRNA increased significantly in both breeds (ponies: P = 0.02; horses: P = 0.02) in response to BW gain. Significant differences in serum GLDH and AST activities, serum bile acid concentrations and hepatic levels of the LPL mRNA were observed between ponies and horses at the end of the study. Conclusions: Chemerin might represent an interesting marker for future equine obesity research. Interestingly, steatosis caused by increasing BW may occur later in the development of obesity in equines than in humans. Additionally, the hepatic metabolism exhibits differences between ponies and horses, which may explain in part the greater susceptibility of ponies to obesity-associated metabolic dysregulations.
Get Full Text
Publication Date: 2019-06-07 PubMed ID: 31211018PubMed Central: PMC6557249DOI: 10.7717/peerj.7069Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article investigates how weight gain impacts liver metabolism and inflammatory cytokines in Shetland pony geldings and Warmblood horse geldings, with a focus on equine obesity and non-alcoholic fatty liver disease (NAFLD). This is important because understanding the impact of weight gain on equine liver metabolism can provide insights into the development of obesity and related metabolic disorders in horses.

Study Design and Methodology

  • The study involved 19 non-obese equines – 10 Shetland pony geldings and nine Warmblood horse geldings.
  • The equines were subjected to a diet containing 200% of their metabolizable maintenance energy requirements for a duration of 2 years to induce weight gain.
  • Various liver markers, such as serum alkaline phosphatase, glutamate dehydrogenase (GLDH), aspartate aminotransferase (AST), and gamma-glutamyl transferase activities and bile acids were analyzed periodically during the study.
  • Additionally, the researchers assessed hepatic lipid content and hepatic levels of various inflammatory molecules such as IL-6, TNFα, CD68, IL-1β, LPL, fatty acid-binding protein 1, chemerin and nuclear factor-κB at the beginning of the study and after 1 and 2 years of excess energy intake.

Key Findings

  • The average weight gain recorded over the study period was 29.9% for ponies and 17% for horses.
  • Despite significant weight gain, hepatic lipid content wasn’t strongly impacted.
  • The levels of hepatic interleukin (IL)-6, tumor necrosis factor α (TNFα), cluster of differentiation (CD) 68, and IL-1β mRNAs remained stable during the weight gain.
  • Levels of the chemerin mRNA significantly increased in both breeds in response to weight gain.
  • Notable differences were found between ponies and horses in terms of serum GLDH and AST activities, serum bile acid concentrations and hepatic levels of the LPL mRNA at the end of the study.

Conclusions

  • The study suggested that chemerin could be a valuable marker for future research on equine obesity.
  • The finding that steatosis (fatty liver disease) may occur later in the development of obesity in equines than in humans is particularly interesting and warrants further investigation.
  • The study’s results also suggest that hepatic metabolism varies between ponies and horses, which might partially explain why ponies are more susceptible to obesity-related metabolic disorders.

Cite This Article

APA
Schedlbauer C, Blaue D, Gericke M, Blüher M, Starzonek J, Gittel C, Brehm W, Vervuert I. (2019). Impact of body weight gain on hepatic metabolism and hepatic inflammatory cytokines in comparison of Shetland pony geldings and Warmblood horse geldings. PeerJ, 7, e7069. https://doi.org/10.7717/peerj.7069

Publication

PeerJ
ISSN: 2167-8359
NlmUniqueID: 101603425
Country: United States
Language: English
Volume: 7
Pages: e7069

Researcher Affiliations

Schedlbauer, Carola
  • Leipzig University, Institute of Animal Nutrition, Nutrition Diseases and Dietetics, Leipzig, Saxony, Germany.
Blaue, Dominique
  • Leipzig University, Institute of Animal Nutrition, Nutrition Diseases and Dietetics, Leipzig, Saxony, Germany.
Gericke, Martin
  • Leipzig University, Institute of Anatomy, Leipzig, Saxony, Germany.
Blüher, Matthias
  • Leipzig University, Department of Medicine, Leipzig, Saxony, Germany.
Starzonek, Janine
  • Leipzig University, Institute of Animal Nutrition, Nutrition Diseases and Dietetics, Leipzig, Saxony, Germany.
Gittel, Claudia
  • Leipzig University, Department for Horses, Leipzig, Saxony, Germany.
Brehm, Walter
  • Leipzig University, Department for Horses, Leipzig, Saxony, Germany.
Vervuert, Ingrid
  • Leipzig University, Institute of Animal Nutrition, Nutrition Diseases and Dietetics, Leipzig, Saxony, Germany.

Conflict of Interest Statement

The authors declare that they have no competing interests.

References

This article includes 52 references
  1. Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A consensus statement from the international diabetes federation.. Diabetic Medicine 2006;23(5):469–480.
    doi: 10.1111/j.1464-5491.2006.01858.xpubmed: 16681555google scholar: lookup
  2. Arner P. Insulin resistance in type 2 diabetes—role of the Adipokines.. Current Molecular Medicine 2005;5(3):333–339.
    doi: 10.2174/1566524053766022pubmed: 15892652google scholar: lookup
  3. Baffy G. Kupffer cells in non-alcoholic fatty liver disease: the emerging view.. Journal of Hepatology 2009;51(1):212–223.
    doi: 10.1016/j.jhep.2009.03.008pmc: PMC2694233pubmed: 19447517google scholar: lookup
  4. Blaue D, Schedlbauer C, Starzonek J, Gittel C, Brehm W, Einspanier A, Vervuert I. Effects of body weight gain on insulin and lipid metabolism in equines.. Domestic Animal Endocrinology 2019;68:111–118.
    doi: 10.1016/j.domaniend.2019.01.003pubmed: 31035090google scholar: lookup
  5. Blüher M. Clinical relevance of adipokines.. Diabetes & Metabolism Journal 2012;36(5):317–327.
    doi: 10.4093/dmj.2012.36.5.317pmc: PMC3486977pubmed: 23130315google scholar: lookup
  6. Bogaert L, van Poucke M, de Baere C, Peelman L, Gasthuys F, Martens A. Selection of a set of reliable reference genes for quantitative real-time PCR in normal equine skin and in equine sarcoids.. BMC Biotechnology 2006;6:24.
    doi: 10.1186/1472-6750-6-24pmc: PMC1484482pubmed: 16643647google scholar: lookup
  7. Bozaoglu K, Bolton K, McMillan J, Zimmet P, Jowett J, Collier G, Walder K, Segal D. Chemerin is a novel adipokine associated with obesity and metabolic syndrome.. Endocrinology 2007;148(10):4687–4694.
    doi: 10.1210/en.2007-0175pubmed: 17640997google scholar: lookup
  8. Burns TA, Geor RJ, Mudge MC, McCutcheon LJ, Hinchcliff KW, Belknap JK. Proinflammatory cytokine and chemokine gene expression profiles in subcutaneous and visceral adipose tissue depots of insulin-resistant and insulin-sensitive light breed horses.. Journal of Veterinary Internal Medicine 2010;24(4):932–939.
    doi: 10.1111/j.1939-1676.2010.0551.xpubmed: 20649750google scholar: lookup
  9. Bussieres G, Jacques C, Lainay O, Beauchamp G, Leblond A, Cadore JL, Desmaizieres LM, Cuvelliez SG, Troncy E. Development of a composite orthopaedic pain scale in horses.. Research in Veterinary Science 2008;85(2):294–306.
    doi: 10.1016/j.rvsc.2007.10.011pubmed: 18061637google scholar: lookup
  10. Carroll CL, Huntington PJ. Body condition scoring and weight estimation of horses.. Equine Veterinary Journal 1988;20(1):41–45.
    doi: 10.1111/j.2042-3306.1988.tb01451.xpubmed: 3366105google scholar: lookup
  11. Carter RA, Geor RJ, Staniar WB, Cubitt TA, Harris PA. Apparent adiposity assessed by standardised scoring systems and morphometric measurements in horses and ponies.. Veterinary Journal 2009a;179(2):204–210.
    doi: 10.1016/j.tvjl.2008.02.029pubmed: 18440844google scholar: lookup
  12. Carter RA, McCutcheon LJ, George LA, Smith TL, Frank N, Geor RJ. Effects of diet-induced weight gain on insulin sensitivity and plasma hormone and lipid concentrations in horses.. Journal of the American Veterinary Medical Association 2009b;235(7):854.
    doi: 10.2460/javma.235.7.854pubmed: 19795940google scholar: lookup
  13. Cash JL, Hart R, Russ A, Dixon JPC, Colledge WH, Doran J, Hendrick AG, Carlton MBL, Greaves DR. Synthetic chemerin-derived peptides suppress inflammation through ChemR23.. Journal of Experimental Medicine 2008;205(4):767–775.
    doi: 10.1084/jem.20071601pmc: PMC2292217pubmed: 18391062google scholar: lookup
  14. Chakaroun R, Raschpichler M, Kloting N, Oberbach A, Flehmig G, Kern M, Schon MR, Shang E, Lohmann T, Dressler M, Fasshauer M, Stumvoll M, Bluher M. Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity.. Metabolism: Clinical and Experimental 2012;61(5):706–714.
    doi: 10.1016/j.metabol.2011.10.008pubmed: 22136911google scholar: lookup
  15. Chameroy KA, Frank N, Elliott SB, Boston RC. Effects of a supplement containing chromium and magnesium on morphometric measurements, resting glucose, insulin concentrations and insulin sensitivity in laminitic obese horses.. Equine Veterinary Journal 2011;43(4):494–499.
    doi: 10.1111/j.2042-3306.2010.00302.xpubmed: 21496075google scholar: lookup
  16. Cortez-Pinto H, Camilo ME, Baptista A, De Oliveira AG, De Moura MC. Non-alcoholic fatty liver: another feature of the metabolic syndrome?. Clinical Nutrition 1999;18(6):353–358.
    pubmed: 10634920
  17. De Meijer VE, Le HD, Meisel JA, Akhavan Sharif MR, Pan A, Nosé V, Puder M. Dietary fat intake promotes the development of hepatic steatosis independently from excess caloric consumption in a murine model.. Metabolism: Clinical and Experimental 2010;59(8):1092–1105.
    doi: 10.1016/j.metabol.2009.11.006pmc: PMC3361716pubmed: 20060143google scholar: lookup
  18. Deng Y, Wang H, Lu Y, Liu S, Zhang Q, Huang J, Zhu R, Yang J, Zhang R, Di Zhang, Shen W, Ning G, Yang Y. Identification of chemerin as a novel FXR target gene down-regulated in the progression of nonalcoholic steatohepatitis.. Endocrinology 2013;154(5):1794–1801.
    doi: 10.1210/en.2012-2126pubmed: 23507574google scholar: lookup
  19. Devers MC, Campbell S, Shaw J, Zimmet P, Simmons D. Should liver function tests be included in definitions of metabolic syndrome? Evidence from the association between liver function tests, components of metabolic syndrome and prevalent cardiovascular disease.. Diabetic Medicine 2008;25(5):523–529.
    doi: 10.1111/j.1464-5491.2008.02408.xpubmed: 18346165google scholar: lookup
  20. Döcke S, Lock JF, Birkenfeld AL, Hoppe S, Lieske S, Rieger A, Raschzok N, Sauer IM, Florian S, Osterhoff MA, Heller R, Herrmann K, Lindenmüller S, Horn P, Bauer M, Weickert MO, Neuhaus P, Stockmann M, Möhlig M, Pfeiffer AFH, Von Loeffelholz C. Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease.. European Journal of Endocrinology 2013;169(5):547–557.
    doi: 10.1530/eje-13-0112pubmed: 23935128google scholar: lookup
  21. Eiler H, Frank N, Andrews FM, Oliver JW, Fecteau KA. Physiologic assessment of blood glucose homeostasis via combined intravenous glucose and insulin testing in horses.. American Journal of Veterinary Research 2005;66(9):1598–1604.
    doi: 10.2460/ajvr.2005.66.1598pubmed: 16261835google scholar: lookup
  22. Figueiredo MD, Salter CE, Andrietti ALP, Vandenplas ML, Hurley DJ, Moore JN. Validation of a reliable set of primer pairs for measuring gene expression by real-time quantitative RT-PCR in equine leukocytes.. Veterinary immunology and immunopathology 2009;131(1-2):65–72.
    doi: 10.1016/j.vetimm.2009.03.013pubmed: 19376596google scholar: lookup
  23. . Empfehlungen zur Energie- und Nährstoffversorgung von Pferden 11.. 2014.
  24. Frank N, Geor RJ, Bailey SR, Durham AE, Johnson PJ. Equine metabolic syndrome.. Journal of Veterinary Internal Medicine 2010;24(3):467–475.
    doi: 10.1111/j.1939-1676.2010.0503.xpubmed: 20384947google scholar: lookup
  25. Gehlen H, May A, Venner M. Lebererkrankungen beim Pferd.. Pferdeheilkunde 2010;26(5):668–679.
  26. Gerspach C, Imhasly S, Klingler R, Hilbe M, Hartnack S, Ruetten M. Variation in fat content between liver lobes and comparison with histopathological scores in dairy cows with fatty liver.. BMC Veterinary Research 2017;13(1):98.
    doi: 10.1186/s12917-017-1004-9pmc: PMC5389092pubmed: 28403840google scholar: lookup
  27. Glatz JFC, Van Der Vusse GJ, Veerkamp JH. Fatty acid-binding proteins and their physiological significance.. Physiology 1988;3(2):41–44.
    doi: 10.1152/physiologyonline.1988.3.2.41google scholar: lookup
  28. Goralski KB, McCarthy TC, Hanniman EA, Zabel BA, Butcher EC, Parlee SD, Muruganandan S, Sinal CJ. Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism.. Journal of Biological Chemistry 2007;282(38):28175–28188.
    doi: 10.1074/jbc.m700793200pubmed: 17635925google scholar: lookup
  29. Haeusler RA, Astiarraga B, Camastra S, Accili D, Ferrannini E. Human insulin resistance is associated with increased plasma levels of 12α-hydroxylated bile acids.. Diabetes 2013;62(12):4184–4191.
    doi: 10.2337/db13-0639pmc: PMC3837033pubmed: 23884887google scholar: lookup
  30. Higuchi N, Kato M, Tanaka M, Miyazaki M, Takao S, Kohjima M, Kotoh K, Enjoji M, Nakamuta M, Takayanagi R. Effects of insulin resistance and hepatic lipid accumulation on hepatic mRNA expression levels of apoB, MTP and L-FABP in non-alcoholic fatty liver disease.. Experimental and Therapeutic Medicine 2011;2(6):1077–1081.
    doi: 10.3892/etm.2011.328pmc: PMC3440820pubmed: 22977624google scholar: lookup
  31. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.. Science 1993;259(5091):87–91.
    doi: 10.1126/science.7678183pubmed: 7678183google scholar: lookup
  32. Johnson PJ, Wiedmeyer CE, LaCarrubba A, Ganjam VKS, Messer NT. Laminitis and the equine metabolic syndrome.. Veterinary Clinics of North America. Equine practice 2010;26(2):239–255.
    doi: 10.1016/j.cveq.2010.04.004pubmed: 20699172google scholar: lookup
  33. Kechagias S, Ernersson A, Dahlqvist O, Lundberg P, Lindström T, Nystrom FH, for the Fast Food Study Group. Fast-food-based hyper-alimentation can induce rapid and profound elevation of serum alanine aminotransferase in healthy subjects.. Gut 2008;57(5):649–654.
    doi: 10.1136/gut.2007.131797pmc: PMC2565580pubmed: 18276725google scholar: lookup
  34. Köller G, Gieseler T, Schusser GF. Hämatologische und blutchemische Referenzbereiche bei Pferden unterschiedlicher Rasse und Altersgruppen basierend auf neuesten labordiagnostischen Methoden.. Pferdeheilkunde 2014;30(4):381–393.
  35. Krautbauer S, Wanninger J, Eisinger K, Hader Y, Beck M, Kopp A, Schmid A, Weiss TS, Dorn C, Buechler C. Chemerin is highly expressed in hepatocytes and is induced in non-alcoholic steatohepatitis liver.. Experimental and Molecular Pathology 2013;95(2):199–205.
    doi: 10.1016/j.yexmp.2013.07.009pubmed: 23906870google scholar: lookup
  36. Lonardo A, Ballestri S, Marchesini G, Angulo P, Loria P. Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome.. Digestive and Liver Disease 2015;47(3):181–190.
    doi: 10.1016/j.dld.2014.09.020pubmed: 25739820google scholar: lookup
  37. Luangsay S, Wittamer V, Bondue B, De Henau O, Rouger L, Brait M, Franssen J-D, De Nadai P, Huaux F, Parmentier M. Mouse ChemR23 is expressed in dendritic cell subsets and macrophages, and mediates an anti-inflammatory activity of chemerin in a lung disease model.. Journal of Immunology 2009;183(10):6489–6499.
    doi: 10.4049/jimmunol.0901037pubmed: 19841182google scholar: lookup
  38. Ma H, Patti ME. Bile acids, obesity, and the metabolic syndrome.. Best Practice & Research Clinical Gastroenterology 2014;28(4):573–583.
    doi: 10.1016/j.bpg.2014.07.004pmc: PMC4159616pubmed: 25194176google scholar: lookup
  39. Pardina E, Baena-Fustegueras JA, Llamas R, Catalán R, Galard R, Lecube A, Fort JM, Llobera M, Allende H, Vargas V, Peinado-Onsurbe J. Lipoprotein lipase expression in livers of morbidly obese patients could be responsible for liver steatosis.. Obesity Surgery 2009;19(5):608–616.
    doi: 10.1007/s11695-009-9827-5pubmed: 19301078google scholar: lookup
  40. Pfaffl MW, Tichopad A, Prgomet C, Neuvians P. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: bestkeeper—excel-based tool using pair-wise correlations.. Biotechnology Letters 2004;26(6):509–515.
    doi: 10.1023/b:bile.0000019559.84305.47pubmed: 15127793google scholar: lookup
  41. Pohl R, Haberl EM, Rein-Fischboeck L, Zimny S, Neumann M, Aslanidis C, Schacherer D, Krautbauer S, Eisinger K, Weiss TS, Buechler C. Hepatic chemerin mRNA expression is reduced in human nonalcoholic steatohepatitis.. European Journal of Clinical Investigation 2017;47(1):7–18.
    doi: 10.1111/eci.12695pubmed: 27797398google scholar: lookup
  42. Qu H, Deng H, Hu Z. Plasma progranulin concentrations are increased in patients with type 2 diabetes and obesity and correlated with insulin resistance.. Mediators of Inflammation 2013;2013:1–6.
    doi: 10.1155/2013/360190pmc: PMC3588183pubmed: 23476101google scholar: lookup
  43. Schmidt ES, Schmidt FW. Glutamate dehydrogenase: biochemical and clinical aspects of an interesting enzyme.. Clinica Chimica Acta 1988;173(1):43–55.
    doi: 10.1016/0009-8981(88)90356-7pubmed: 3289795google scholar: lookup
  44. Shi J, Zhang Y, Gu W, Cui B, Xu M, Yan Q, Wang W, Ning G, Hong J. Serum liver fatty acid binding protein levels correlate positively with obesity and insulin resistance in Chinese young adults.. PLOS ONE 2012;7(11):e48777.
    doi: 10.1371/journal.pone.0048777pmc: PMC3492433pubmed: 23144966google scholar: lookup
  45. Siegers EW, De Ruijter-Villani M, Van Doorn DA, Stout TAE, Roelfsema E. Ultrasonographic measurements of localized fat accumulation in Shetland pony mares fed a normal v. a high energy diet for 2 years.. Animal 2018;12(8):1602–1610.
    doi: 10.1017/s1751731117003251pubmed: 29198235google scholar: lookup
  46. Sookoian S, Castano GO, Scian R, Fernandez Gianotti T, Dopazo H, Rohr C, Gaj G, San Martino J, Sevic I, Flichman D, Pirola CJ. Serum aminotransferases in nonalcoholic fatty liver disease are a signature of liver metabolic perturbations at the amino acid and Krebs cycle level.. American Journal of Clinical Nutrition 2016;103(2):422–434.
    doi: 10.3945/ajcn.115.118695pubmed: 26791191google scholar: lookup
  47. Ungru J, Blüher M, Coenen M, Raila J, Boston R, Vervuert I. Effects of body weight reduction on blood adipokines and subcutaneous adipose tissue adipokine mRNA expression profiles in obese ponies.. The Veterinary record 2012;171(21):528.
    doi: 10.1136/vr.100911pubmed: 23042851google scholar: lookup
  48. Vick MM, Adams AA, Murphy BA, Sessions DR, Horohov DW, Cook RF, Shelton BJ, Fitzgerald BP. Relationships among inflammatory cytokines, obesity, and insulin sensitivity in the horse.. Journal of Animal Science 2007;85(5):1144–1155.
    doi: 10.2527/jas.2006-673pubmed: 17264235google scholar: lookup
  49. Vozarova B, Weyer C, Hanson K, Tataranni PA, Bogardus C, Pratley RE. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion.. Obesity Research 2001;9(7):414–417.
    doi: 10.1038/oby.2001.54pubmed: 11445664google scholar: lookup
  50. Weigert J, Neumeier M, Wanninger J, Filarsky M, Bauer S, Wiest R, Farkas S, Scherer MN, Schäffler A, Aslanidis C, Schölmerich J, Buechler C. Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes.. Clinical Endocrinology 2010;72(3):342–348.
    doi: 10.1111/j.1365-2265.2009.03664.xpubmed: 19558533google scholar: lookup
  51. Yoshimura T, Oppenheim JJ. Chemerin reveals its chimeric nature.. Journal of Experimental Medicine 2008;205(10):2187–2190.
    doi: 10.1084/jem.20081736pmc: PMC2556799pubmed: 18809717google scholar: lookup
  52. Zhang L, Ma X, Jiang Z, Zhang K, Zhang M, Li Y, Zhao X, Xiong H. Liver enzymes and metabolic syndrome: a large-scale case-control study.. Oncotarget 2015;6(29):26782–26788.
    doi: 10.18632/oncotarget.5792pmc: PMC4694952pubmed: 26449189google scholar: lookup
Subscribe to our newsletter
Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.